Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge.&nbspClick  here to subscribe.

BPAC issues recommendations on OraQuick

---

The Blood Products Advisory Committee voted unanimously that the benefits of the OraQuick In-Home HIV Test outweigh the possi&nbsp-More- 

Donor Recruiting & Retention Got Easier TODAY
Mobile apps are changing the way we work, play, socialize, learn &#8212 and live. Now, theyre changing the way we recruit and retain blood donors too. Welcome to the mobile app revolution. The future of donor recruiting and retention is here NOW. Learn more.

Stem cell-sparing method could help patients with neck, head cancers

---

Dutch researchers developed a mathematical model to test a method that could help protect stem cells during radiotherapy and &nbsp-More- 

Researchers use human ESCs to grow bone tissue grafts

---

U.S. &nbsp-More- 

Placental cells boost heart function in mice with diabetes

---

A stem cell treatment derived from placental cells helped boost heart function in mice with diabetes-induced diastolic dysfun&nbsp-More- 

Discount on Regenerative Medicine Journal offered to AABB members
AABB has partnered with Regenerative Medicine Journal to offer a six-issue online subscription for $30 to AABB members. This journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine. Visit the AABB Marketplace or add-on to your online AABB membership renewal.

Nigerian bone-marrow registry could spur matches in U.S.

---

A man who emigrated from Nigeria to the U.S. &nbsp-More- 

HHS releases Web-based tool for evaluating health data

---

HHS has introduced a Web-based tool called the Health System Measurement Project to simplify public monitoring and searching &nbsp-More- 

LifeSouth releases statement in light of recent HIV case

---

LifeSouth Community Blood Centers has been sued by a man who alleges he contracted HIV from infected blood provided by the bl&nbsp-More- 

Funding round brings in $10 million for stem cell therapy developer

---

Gamida Cell has secured $10 million in its latest financing round. &nbsp-More- 

CryoLife to pay $17 million for HemoSphere

---

CryoLife has agreed to pay $17 million to acquire HemoSphere, the maker of a device designed to cut the risk of infection in &nbsp-More- 

Senator proposes prizes instead of patents for HIV drugs

---

Sen. &nbsp-More- 

FDA expedites review of experimental hepatitis C drug

---

Achillion Pharmaceuticals hepatitis C drug candidate ACH-3102 received fast-track status from the FDA. &nbsp-More- 

Participate in the HPC Triggers Practice Snapshot

---

AABBs CT Product Collection and Clinical Practices Subsection is encouraging participation in the HPC Triggers Practice Snap&nbsp-More- 

Regional Director of Transfusion Services
Advocate Health Care

I finally figured out the only reason to be alive is to enjoy it.

---

Rita Mae Brown,American writer&nbsp-More-